Medanta launches FemtoLASIK, a bladeless refractive treatment
Medanta, India’s one of the huge multi-super specialty institute, which is located in Gurgaon, revealed the launch of FemtoLASIK. It is a revolutionary technology and is the most advanced Lasik treatment available across the globe allowing bladeless refractive treatment.
As per the chairman and founder of Medanta, Dr. Naresh Trehan, Medanta is continuously making efforts to launch innovative medical technologies across the world in Gurgaon and offer the optimum cure to every patient. The launch of FemtoLASIK underlines company’s commitment to build up ophthalmology division at the Medicity and offer complete medical treatment under one roof.
The FemtoLASIK technology is highly advanced procedure targeted at enhancing patient’s quality of life by minimising his dependence on glasses. Globally known, Lasik technology is the at present considered as the state-of-the-art in refractive surgery. It functions by changing the shape of the cornea to treat myopia, hypermetropia, and astigmatism.
As per the chairman, Institute of Ophthalmology at Medanta - The Medicity, Dr. Sudipto Pakrasi, FemtoLASIK’s bladeless technology enables the production of flaps with wide range diameter and thickness. This creates a very accurate and smooth corneal flaps to make sure precise treatment is given with reduced risk. This is one of the safe Lasik treatments available across the globe today.
According to Pharmaion, pharma and healthcare consultants, the launch of most advanced treatment will boost research and development across the world’s leading companies involved in eye treatment and surgery. The companies will compete to come up with the more advanced Lasik treatment.